From Seed to Scale: Investing Early in High-Impact HealthTech

​We’re excited to invite you to a webinar with Sherwood Neiss, founder of D3VC, one of the originators of Equity Crowdfunding, and Managing General Partner of D3VC, an investor in HCO! 🌟

​Sherwood Neiss, one of the co-authors of the “Crowdfunding Exemption Framework”, which became the basis of the act to legalize equity and lending-based crowdfunding. We’re able to meet all of you and democratize access on this platform because of the work of Sherwood and his co-authors, so this is an amazing opportunity to hear directly from one of the thought-leaders in this space.

​It’s extraordinarily impactful, then that as Managing General Partner of D3VC, Sherwood led D3VC’s investment in HCO! 

​This discussion will explore the future of early-stage investing and why HCO is an extraordinary investment opportunity. 

​Equity crowdfunding is becoming a go-to strategy for Seed and Series A funding. We’ll have an in-depth discussion on how this creates a unique opportunity to invest in game-changing startups at their earliest stage and lowest valuations, with HCO as a prime example, but also discuss the topic of why equity crowdfunding is smart money.